Catalyst Wire Dossier Catalyst Wire Dossier

Lodivikar

· Hanlim Pharm. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lodivikar, covering 2016-11-04 to 2016-11-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects [Phase 1]

See pricing